These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 638991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Definitive end-stage chronic kidney failure after cisplatin treatment].
    Brillet G, Deray G, Lucsko M, Faucher C, Aubert P, Rottembourg J, Jacobs C.
    Nephrologie; 1993; 14(5):227-9. PubMed ID: 8159252
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Measures of renal function in patients with cisplatin-related chronic renal disease.
    Reed E, Jacob J, Brawley O.
    J Natl Med Assoc; 1991 Jun; 83(6):522-6. PubMed ID: 1865503
    [Abstract] [Full Text] [Related]

  • 7. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A, Yoshida T, Tsukuda M, Furukawa S, Miyata K, Mochimatsu I, Sawaki S.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [Abstract] [Full Text] [Related]

  • 8. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
    Yoshida T, Kumagai H, Kohsaka T, Ikegaya N.
    Nephron Exp Nephrol; 2014 Aug; 128(1-2):9-20. PubMed ID: 25403022
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Combination effects of cis-dichlorodiammineplatinum (II) and sodium thiosulfate on renal dysfunction].
    Hirosawa A, Sakai S, Iizuka K, Niitani H, Hayashibara K, Tsuboi E.
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2870-5. PubMed ID: 3662543
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
    Saad SY, Al-Rikabi AC.
    Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
    Yapar K, Cavuşoğlu K, Oruç E, Yalçin E.
    J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
    [Abstract] [Full Text] [Related]

  • 16. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats.
    Saad SY, Najjar TA, Alashari M.
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):862-7. PubMed ID: 15659050
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of cisplatin on renal function in patients with testicular tumours.
    MacLeod PM, Tyrell CJ, Keeling DH.
    Clin Radiol; 1988 Mar; 39(2):190-2. PubMed ID: 3128418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.